NCT04926571View on ClinicalTrials.gov

Dexamethasone and COVID-19 Inpatient Mortality

CompletedOBSERVATIONAL
Enrollment

14,105

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

August 27, 2021

Study Completion Date

August 27, 2021

Conditions
Coronavirus
Interventions
DRUG

Dexamethasone Oral

New users of Dexamethasone

Trial Locations (1)

10001

Aetion, Inc., New York

All Listed Sponsors
lead

Aetion, Inc.

OTHER

NCT04926571 - Dexamethasone and COVID-19 Inpatient Mortality | Biotech Hunter | Biotech Hunter